Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 41

    1.

    Finding ovarian cancer.

    Hartge P, Speyer JL.

    J Natl Cancer Inst. 2012 Jan 18;104(2):82-3. Epub 2012 Jan 13. No abstract available.

    PMID:
    22247023
    [PubMed - indexed for MEDLINE]
    2.

    Predictive value of symptoms for ovarian cancer: comparison of symptoms reported by questionnaire, interview, and general practitioner notes.

    Lim AW, Mesher D, Gentry-Maharaj A, Balogun N, Jacobs I, Menon U, Sasieni P.

    J Natl Cancer Inst. 2012 Jan 18;104(2):114-24. Epub 2012 Jan 13.

    PMID:
    22247022
    [PubMed - indexed for MEDLINE]
    3.

    Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

    Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Isaacs C, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Ragard LR, Clapp JD, Rathmell JM, Riley TL, Hsing AW, Izmirlian G, Pinsky PF, Kramer BS, Miller AB, Gohagan JK, Prorok PC; PLCO Project Team.

    J Natl Cancer Inst. 2012 Jan 18;104(2):125-32. Epub 2012 Jan 6.

    PMID:
    22228146
    [PubMed - indexed for MEDLINE]
    4.

    Silencing of p130cas in ovarian carcinoma: a novel mechanism for tumor cell death.

    Nick AM, Stone RL, Armaiz-Pena G, Ozpolat B, Tekedereli I, Graybill WS, Landen CN, Villares G, Vivas-Mejia P, Bottsford-Miller J, Kim HS, Lee JS, Kim SM, Baggerly KA, Ram PT, Deavers MT, Coleman RL, Lopez-Berestein G, Sood AK.

    J Natl Cancer Inst. 2011 Nov 2;103(21):1596-612. Epub 2011 Sep 28.

    PMID:
    21957230
    [PubMed - indexed for MEDLINE]
    5.

    Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

    Urban N, Thorpe JD, Bergan LA, Forrest RM, Kampani AV, Scholler N, O'Briant KC, Anderson GL, Cramer DW, Berg CD, McIntosh MW, Hartge P, Drescher CW.

    J Natl Cancer Inst. 2011 Nov 2;103(21):1630-4. Epub 2011 Sep 14.

    PMID:
    21917606
    [PubMed - indexed for MEDLINE]
    6.

    CA-125: a biomarker put to the test.

    Schmidt C.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1290-1. Epub 2011 Aug 17. No abstract available.

    PMID:
    21852262
    [PubMed - indexed for MEDLINE]
    7.

    Ovarian cancer genome sequencing unveils findings.

    Brower V.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1288-90. Epub 2011 Aug 17. No abstract available.

    PMID:
    21852263
    [PubMed - indexed for MEDLINE]
    8.

    Ovarian cancer treatments on the horizon.

    Schmidt C.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1284-5. Epub 2011 Aug 17. No abstract available.

    PMID:
    21852261
    [PubMed - indexed for MEDLINE]
    9.

    Ovarian cancer, five-year stage-specific relative survival rates (2004-2008).

    [No authors listed]

    J Natl Cancer Inst. 2011 Sep 7;103(17):1287. Epub 2011 Aug 17. No abstract available.

    PMID:
    21852260
    [PubMed - indexed for MEDLINE]
    10.

    Oral contraceptives as ovarian cancer prevention.

    Crane K.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1286-8. Epub 2011 Aug 17. No abstract available.

    PMID:
    21852259
    [PubMed - indexed for MEDLINE]
    11.

    Early decline in cancer antigen 125 as a surrogate for progression-free survival in recurrent ovarian cancer.

    Lee CK, Friedlander M, Brown C, Gebski VJ, Georgoulopoulos A, Vergote I, Pignata S, Donadello N, Schmalfeldt B, Delva R, Mirza MR, Sauthier P, Pujade-Lauraine E, Lord SJ, Simes RJ.

    J Natl Cancer Inst. 2011 Sep 7;103(17):1338-42. Epub 2011 Aug 11.

    PMID:
    21840849
    [PubMed - indexed for MEDLINE]
    12.

    The role of p27(Kip1) in dasatinib-enhanced paclitaxel cytotoxicity in human ovarian cancer cells.

    Le XF, Mao W, He G, Claret FX, Xia W, Ahmed AA, Hung MC, Siddik ZH, Bast RC Jr.

    J Natl Cancer Inst. 2011 Sep 21;103(18):1403-22. Epub 2011 Aug 2.

    PMID:
    21813412
    [PubMed - indexed for MEDLINE]
    13.

    Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

    Tammemagi CM, Pinsky PF, Caporaso NE, Kvale PA, Hocking WG, Church TR, Riley TL, Commins J, Oken MM, Berg CD, Prorok PC.

    J Natl Cancer Inst. 2011 Jul 6;103(13):1058-68. Epub 2011 May 23.

    PMID:
    21606442
    [PubMed - indexed for MEDLINE]
    14.

    Therapeutic potential of poly(ADP-ribose) polymerase inhibitor AG014699 in human cancers with mutated or methylated BRCA1 or BRCA2.

    Drew Y, Mulligan EA, Vong WT, Thomas HD, Kahn S, Kyle S, Mukhopadhyay A, Los G, Hostomsky Z, Plummer ER, Edmondson RJ, Curtin NJ.

    J Natl Cancer Inst. 2011 Feb 16;103(4):334-46. Epub 2010 Dec 23.

    PMID:
    21183737
    [PubMed - indexed for MEDLINE]
    Free Article
    15.

    Materials scientists join oncologists to explore nano- and microtherapeutics.

    Martin M.

    J Natl Cancer Inst. 2011 Feb 2;103(3):172-3, 177. Epub 2011 Jan 17. No abstract available.

    PMID:
    21242336
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Randomized phase III clinical trial evaluating weekly cisplatin for advanced epithelial ovarian cancer.

    Fruscio R, Garbi A, Parma G, Lissoni AA, Garavaglia D, Bonazzi CM, Dell'anna T, Mangioni C, Milani R, Colombo N.

    J Natl Cancer Inst. 2011 Feb 16;103(4):347-51. Epub 2011 Jan 7.

    PMID:
    21217084
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Inference from a multiplicative model of joint genetic effects for [corrected] ovarian cancer risk.

    Wacholder S, Han SS, Weinberg CR.

    J Natl Cancer Inst. 2011 Jan 19;103(2):82-3. Epub 2010 Dec 17. No abstract available. Erratum in: J Natl Cancer Inst. 2011 Jun 8;103(11):906.

    PMID:
    21169538
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    18.

    Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

    Ramus SJ, Kartsonaki C, Gayther SA, Pharoah PD, Sinilnikova OM, Beesley J, Chen X, McGuffog L, Healey S, Couch FJ, Wang X, Fredericksen Z, Peterlongo P, Manoukian S, Peissel B, Zaffaroni D, Roversi G, Barile M, Viel A, Allavena A, Ottini L, Papi L, Gismondi V, Capra F, Radice P, Greene MH, Mai PL, Andrulis IL, Glendon G, Ozcelik H; OCGN, Thomassen M, Gerdes AM, Kruse TA, Cruger D, Jensen UB, Caligo MA, Olsson H, Kristoffersson U, Lindblom A, Arver B, Karlsson P, Stenmark Askmalm M, Borg A, Neuhausen SL, Ding YC, Nathanson KL, Domchek SM, Jakubowska A, Lubiński J, Huzarski T, Byrski T, Gronwald J, Górski B, Cybulski C, Dębniak T, Osorio A, Durán M, Tejada MI, Benítez J, Hamann U, Rookus MA, Verhoef S, Tilanus-Linthorst MA, Vreeswijk MP, Bodmer D, Ausems MG, van Os TA, Asperen CJ, Blok MJ, Meijers-Heijboer HE; HEBON; EMBRACE, Peock S, Cook M, Oliver C, Frost D, Dunning AM, Evans DG, Eeles R, Pichert G, Cole T, Hodgson S, Brewer C, Morrison PJ, Porteous M, Kennedy MJ, Rogers MT, Side LE, Donaldson A, Gregory H, Godwin A, Stoppa-Lyonnet D, Moncoutier V, Castera L, Mazoyer S, Barjhoux L, Bonadona V, Leroux D, Faivre L, Lidereau R, Nogues C, Bignon YJ, Prieur F, Collonge-Rame MA, Venat-Bouvet L, Fert-Ferrer S; GEMO Study Collaborators, Miron A, Buys SS, Hopper JL, Daly MB, John EM, Terry MB, Goldgar D; BCFR, Hansen TO, Jønson L, Ejlertsen B, Agnarsson BA, Offit K, Kirchhoff T, Vijai J, Dutra-Clarke AV, Przybylo JA, Montagna M, Casella C, Imyanitov EN, Janavicius R, Blanco I, Lázaro C, Moysich KB, Karlan BY, Gross J, Beattie MS, Schmutzler R, Wappenschmidt B, Meindl A, Ruehl I, Fiebig B, Sutter C, Arnold N, Deissler H, Varon-Mateeva R, Kast K, Niederacher D, Gadzicki D, Caldes T, de la Hoya M, Nevanlinna H, Aittomäki K, Simard J, Soucy P; kConFab Investigators, Spurdle AB, Holland H, Chenevix-Trench G, Easton DF, Antoniou AC; Consortium of Investigators of Modifiers of BRCA1/2.

    J Natl Cancer Inst. 2011 Jan 19;103(2):105-16. Epub 2010 Dec 17.

    PMID:
    21169536
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    19.

    Targeted epigenetic therapies: the next frontier?

    Tuma RS.

    J Natl Cancer Inst. 2010 Dec 15;102(24):1824-5. Epub 2010 Dec 7. No abstract available.

    PMID:
    21139098
    [PubMed - indexed for MEDLINE]
    Free Article
    20.

    Family history of cancer and cancer risks in women with BRCA1 or BRCA2 mutations.

    Metcalfe K, Lubinski J, Lynch HT, Ghadirian P, Foulkes WD, Kim-Sing C, Neuhausen S, Tung N, Rosen B, Gronwald J, Ainsworth P, Sweet K, Eisen A, Sun P, Narod SA; Hereditary Breast Cancer Clinical Study Group.

    J Natl Cancer Inst. 2010 Dec 15;102(24):1874-8. Epub 2010 Nov 23.

    PMID:
    21098759
    [PubMed - indexed for MEDLINE]
    Free Article

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk